MMP9 and central nervous system cancer: Furthermore, an uptick in MMP2/9 was observed within the hsa-miR-134-5p mimic groups, suggesting an inhibition of glioma cell cycle progression influenced by hsa-miR-134-5p’s suppression of MMP2/MMP9 (Figure 3B).